Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 6/20 | 0.65 |
| ▸ | FFAR4 | Q5NUL3 | 4/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.64 |
| ▸ | F7 | P08709 | 6/20 | 0.64 |
| ▸ | F3 | P13726 | 6/20 | 0.64 |
| ▸ | PPARG | P37231 | 4/20 | 0.64 |
| ▸ | PPARD | Q03181 | 4/20 | 0.64 |
| ▸ | PPARA | Q07869 | 4/20 | 0.64 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.64 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.64 |
| ▸ | OXER1 | Q8TDS5 | 2/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | HPGD | P15428 | 2/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30458023 | 0.94 | FFAR1 (0.71) | FFAR1FFAR4F7F3PPARG | |
| SCHEMBL30457666 | 0.94 | FFAR1 (0.71) | FFAR1FFAR4F7F3PPARG | |
| SCHEMBL30458046 | 0.94 | FFAR1 (0.71) | FFAR1FFAR4F7F3PPARG | |
| SCHEMBL10081556 | 0.94 | FFAR1 (0.71) | FFAR1FFAR4F7F3PPARG | |
| SCHEMBL30457930 | 0.94 | FFAR1 (0.71) | FFAR1FFAR4F7F3PPARG | |
| SCHEMBL17128751 | 0.94 | FFAR1 (0.71) | FFAR1FFAR4F7F3PPARG | |
| SCHEMBL3022861 | 0.93 | FFAR1 (0.69) | FFAR1FFAR4F7F3PPARG | |
| SCHEMBL3367824 | 0.92 | FFAR1 (0.60) | FFAR1FFAR4ALDH1A1F7F3 | |
| SCHEMBL27968801 | 0.89 | NFKB1 (0.75) | FFAR1FFAR4ALDH1A1F7F3 | |
| SCHEMBL18258540 | 0.89 | NFKB1 (0.75) | FFAR1FFAR4ALDH1A1F7F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240189235-A1 | CATIONIC LIPIDS AND USES THEREOF | MELLO BIOTECH TAIWAN CO., LTD. (TW) | 2024-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240189235-A1 | CATIONIC LIPIDS AND USES THEREOF | LIPA, APOB, NPC1 | FFAR1 1225/4885FFAR4 2198/4885ALDH1A1 3523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.